Simple blood tests could spot liver damage early in diabetics

NCT ID NCT06567990

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is testing whether simple blood tests and a liver scan can accurately track liver disease progression in 500 people with type 2 diabetes. Participants will be followed over time to see if these non-invasive tools can replace liver biopsies for detecting advanced scarring. The goal is to make screening easier and catch serious liver problems earlier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Non-invasive blood tests and imaging (FibroScan)
What this could lead to
If successful, this could lead to better, simpler ways to detect liver disease progression early in people with type 2 diabetes, potentially preventing severe complications.
What could go wrong
This is an observational study, not a treatment trial. The biomarkers may not prove accurate enough to change clinical practice, and results may take years to confirm.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition CIC Endocrino-Nut

    RECRUITING

    Nantes, 44093, France

  • Endocrinologie, Diabète et Nutrition in Louis PRADEL Hospital

    RECRUITING

    Lyon, 69677, France

  • Service Endocrinologie, Diabétologie, Maladies Métaboliques et Nutrition

    RECRUITING

    Dijon, BP 1542- 14, France

  • Service d'Endocrinologie, Diabète et nutrition

    RECRUITING

    Pierre-Bénite, 69495, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.